未登录

W

Won Gu Kim

Asan Medical Center

H指数:54

被引数:8,920

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjusted calcitonin levels and lateral lymph node metastasis in medullary thyroid carcinoma

降钙素水平调整与髓样甲状腺癌的侧方淋巴结转移

Asian Journal of Surgery

IF3.8

2026-05-250

OAAI

Prognostic Significance of Detectable Antithyroglobulin Antibodies Based on Analytical Sensitivity in Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin after Radioactive Iodine Treatment

基于分析灵敏度的可检测抗甲状腺球蛋白抗体在放射性碘治疗后血清甲状腺球蛋白不可检测的乳头状甲状腺癌中的预后意义

IF6.7

2026-01-010

PRE

Clinical outcomes of malignant pleural effusion in patients with lung metastases from differentiated thyroid cancer

ENDOCRINE-RELATED CANCER

IF4.6

2025-11-010

PRE

Preoperative controlling nutritional status score for patients with medullary thyroid cancer

术前控制营养状况评分（Controlled Onset Preoperative Nutritional Status Score）用于髓样甲状腺癌患者

IF2.9

2025-05-100

PRE

Trends in Thyroid Cancer Mortality Rates in Korea: Insights from National Health Database

ENDOCRINOLOGY AND METABOLISM

IF4.2

2024-12-310

OAAI

Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer

IF6.7

2024-09-011

PRE

Dynamic Risk Model for the Medical Treatment of Graves' Hyperthyroidism according to Treatment Duration

ENDOCRINOLOGY AND METABOLISM

IF4.2

2024-08-311

OAAI

Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: 10-Year Experience

射频消融治疗甲状腺良性结节10年经验

IF6.7

2024-08-012

PRE

Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma

IF6.7

2024-07-011

PRE

Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib

ENDOCRINOLOGY AND METABOLISM

IF4.2

2024-04-300

OAAI

Morphometric Analysis of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Digital Pathology

ENDOCRINE PATHOLOGY

IF14.7

2023-12-082

PRE

Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration

IF2.9

2023-11-231

PRE

Contralateral Low-to-Intermediate Suspicion Nodule is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma

IF6.7

2023-11-012

PRE

Long-Term Changes in the Mortality Rates of Thyroid Cancer in Korea: Analysis of Korean National Data from 1985 to 2020

ENDOCRINOLOGY AND METABOLISM

IF4.2

2023-10-315

OAAI

Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib

SCIENTIFIC REPORTS

IF3.9

2023-08-071

OAAI

Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (vol 32, pg 106, 2017)

ENDOCRINOLOGY AND METABOLISM

IF4.2

2023-06-300

OAAI

Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib

IF2.9

2023-03-163

PRE

Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma

IF2.9

2023-03-138

PRE

Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort

EUROPEAN THYROID JOURNAL

IF4.3

2023-02-2411

OAAI

Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data

ENDOCRINOLOGY AND METABOLISM

IF4.2

2022-10-3114

OAAI